Raiffeisen Bank International’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Raiffeisen Bank International's LLY Position: Q1 2026 in Review
Raiffeisen Bank International reduced its Eli Lilly (LLY) stake by 4.1% in Q1 2026, selling an estimated $5.89M and leaving 136,080 shares worth $121M. The position accounts for 1.73% of the portfolio, ranked #8.
Raiffeisen Bank International first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $153M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Raiffeisen Bank International held 136,080 shares of Eli Lilly worth $121M as of Q1 2026.
- Raiffeisen Bank International sold 5,808 Eli Lilly shares in Q1 2026, an estimated $5.89M.
- Eli Lilly made up 1.73% of Raiffeisen Bank International's portfolio in Q1 2026, its #8 holding.
- Raiffeisen Bank International first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Raiffeisen Bank International's Eli Lilly position peaked at $153M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.